Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
Age: 18 - 100 years
Gender: All
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
The purpose of the study is to learn how the study medicine called PF-07868489 is
tolerated and acts in healthy adult people and people with pulmonary arterial
hypertension (PAH).
Part A:
An investigator- and participant-blind, sponsor-open, placebo-controlled, ...
Age: 18 - 65 years
Gender: All
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A prospective, multinational, randomized, double-blind, clinical trial evaluating the
safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm
downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
Age: 18 years - 66+
Gender: All
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
This is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control)
clinical trial. The purpose of the study is to determine the role of adjunctive renal
sympathetic denervation in the prevention of Atrial Fibrillation (AF) recurrence in
patients ...
Age: 18 years - 66+
Gender: All
Healthy Mediation Adherence To Transform and Effectively Relieve Symptoms
The goal of the parent R01 study has been to determine how beliefs about chronic illness and their treatments affect SMB in the context of chronic obstructive pulmonary disease (COPD) with comorbid hypertension (HTN) and or diabetes (DM). The educational counseling modu...
Age: Birth - 66+
Gender: All
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
This study is a prospective Phase IV study to determine if the use of Everolimus results
in lower liver tumor recurrence and improved patient and graft survival after liver
transplant for hepatocellular carcinoma (HCC). The immunosuppressive comparators will be
Evero...
Age: 18 years - 66+
Gender: All